|
|
Overview
The Office of Planning, in partnership with FDA senior management, guides the Agency through its rapidly changing environment to attain significant public health outcomes. Our planning function identifies emerging issues with the greatest potential impact on FDA and establishes forums for dialogue among FDA leaders that produce knowledge, shape new strategies, establish priorities and optimize use of resources and provide information and analyses that helps FDA officials, the Department, and members of Congress make decisions related to programs, policies, budgets, and strategic planning.
Our Mission
The Office of Planning implements the Agency's responsibilities
associated with the Government Performance and Results Act, the
Prescription Drug User Fee Act, and Executive Orders pertaining
to economic analysis of regulatory policies and OMB/HHS directives
regarding strategic management. These responsibilities include the
following:
- Design and develop strategic plans, performance management
systems, and operational/business process plans.
- Analyze management performance trends, Agency cost structure,
and use of program resources.
- Oversee the Prescription Drug and User Fee Act of 2002 performance
and use of resources.
- Analyze cost and benefits of agency regulations.
- Provide assistance to Agency components in change management,
program reinvention, and managing-to-cost.
- Analyze changes in domestic health-care system and changes in
international and trade issues that relate to FDA responsibilities.
|
|
|
|
Outlines how FDA is taking new steps to protect and advance public
health. The plan sets a framework for achieving four broad goals
for the Agency.
Analyses of the economic impact of new and revised regulatory requirements
on affected industries.
Information about this act, including links to the performance
and financial plans since 1995.
Description of this act, with links to News Updates and full text of the act.
Description of the purpose and requirements of this act, with links
to FDA's performance plans since 1999. |
|
|
|
|
|